RecruitingMyasthenia GravisMGgMG
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Eligible age
18+ yrs
Accepts
All genders
Locations
10 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
ADAPT Forward is a platform study with the aim to look at how safe different drugs are and how well they work for people with myasthenia gravis. The goal is to find the best therapeutic approach to reduce patients' side effects and improve their quality of life.
Sponsor: argenx
You may qualify if…
- ✓ Is at least 18 years of age and the local legal age of consent for clinical studies
- ✓ Has been diagnosed with MG with consistent clinical features per the investigator's clinical judgment
- ✓ If receiving MG therapy, including nonsteroidal immunosuppressive drugs (NSIDs), corticosteroids, or acetylcholinesterase (AChE) inhibitors either in combination or alone, the participant should receive a stable dosage before master protocol screening
You may not qualify if…
- ✕ Known autoimmune disease or any medical condition other than the indication under study that would interfere with an accurate assessment of clinical symptoms of MG or puts the participant at undue risk
- ✕ Is MGFA (Myasthenia Gravis Foundation of America) Class V
Where it's recruiting
California
Carlsbad
Florida
Miami · Tampa
Massachusetts
Boston
Michigan
Detroit
Nevada
Las Vegas
New York
Amherst
North Carolina
Chapel Hill · Durham
Ohio
Cincinnati · Columbus
Tennessee
Chattanooga
Texas
Austin · San Antonio
Source: ClinicalTrials.gov · NCT07294170 · last updated 2026-10-26